You've heard of probiotics, the living organisms that colonise our gastrointestinal tract and beyond to keep our inner ecology balanced and healthy. Immunobiotics are the new frontier.
Immuno-LP20™ is the first natural immunobiotic to emerge on the world market. Already established in Japan where it was developed by Japanese scientists, Immuno-LP20 is a heat-killed strain of Lactobacillus plantarum (L-137), a lactic acid bacteria commonly found in a wide variety of fermented foods.
As a live organism, L. plantarum is considered a beneficial probiotic; but its immune-supporting benefits are inhibited by its structure and lack of stability within digestive fluid. Immuno-LP20 is heat treated at a precise moment during the growth phase to break down the cell membrane and components, eliminating the inhibitors and stabilising the product for survival in the gastric fluids. This allows for a powerful stimulating effect on the production of IL-12, an important factor in immune system function.
Research shows that Immuno-LP20 is active within the small intestine, where it passes through the intestinal lumen to stimulate production of IL-2 and IFN-β. IL-12 in turn, produces T cells and activates effector cells such as NK cells and CTLs. IFN-β is one of the most important cytokines directly involved in immune defence.